| View |
|
DRP-5052-27
|
Cefixime (as Trihydrate)
|
Luxime
|
100 mg / 5 mL
|
Granules for Suspension
|
Antibacterial (Third Generation Cephalosporin)
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
22 February 2024
|
18 August 2027
|
| View |
|
DRP-5052-28
|
Cefixime (as trihydrate)
|
Sufixime
|
100 mg/5 mL
|
Granules for Supension
|
Antibacterial (Third Generation Cephalosporin)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
19 February 2024
|
18 August 2027
|
| View |
|
DRP-5129-07
|
Zoledronic Acid (as monohydrate)
|
Zologet
|
4 mg
|
Lyophilized Powder for IV Infusion
|
Bisphosphonates
|
Getwell Pharmaceuticals
|
India
|
CLIDP Conversion
|
26 January 2024
|
20 February 2029
|
| View |
|
DRP-5177-01
|
Esomeprazole (as sodium)
|
Esoziem
|
40 mg
|
Lyophilized Powder for IV Injection/Infusion
|
Proton Pump Inhibitor
|
Sovereign Pharma Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 February 2024
|
20 February 2029
|
| View |
|
DRP-5183-04
|
Paracetamol + Tramadol Hydrochloride
|
Primetram
|
325 mg/37.5 mg
|
Film-Coated Tablet
|
Antipyretic/Opioid Analgesic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
01 March 2024
|
25 February 2029
|
| View |
DRP-5317-03_PI_01.pdf
|
DRP-5317-03
|
Cinnarizine
|
Vercure
|
75 mg
|
Capsule
|
Anti-Vertigo
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
18 February 2024
|
24 December 2028
|
| View |
|
DRP-5343-05
|
Co-Amoxiclav
|
Duoxiclav
|
1 g
|
Film-Coated Tablet
|
Antibacterial (Penicillins)
|
Giyaan Pharma Private Limited
|
India
|
Renewal
|
07 April 2024
|
17 June 2029
|
| View |
|
DRP-5367-05
|
Cefuroxime (as Axetil)
|
Educef-250
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
01 February 2024
|
30 June 2029
|
| View |
|
DRP-5367-09
|
Cefuroxime (as Axetil)
|
Cefuphil
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
05 February 2024
|
30 June 2029
|
| View |
|
DRP-5421-11
|
Telmisartan
|
Curatel
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Healer's Lab Unit II
|
India
|
Renewal
|
04 August 2024
|
05 August 2029
|
| View |
|
DRP-5463-03
|
Olanzapine
|
Olanzgrand 5
|
5 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Ravian Life Science Pvt. Ltd.
|
India
|
Renewal
|
28 August 2024
|
18 August 2029
|
| View |
|
DRP-5585-02
|
Olanzapine
|
Zilano 5 ODT
|
5 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Jubilant Generics Limited
|
India
|
CLIDP Conversion
|
23 February 2024
|
28 March 2029
|
| View |
|
DRP-5683-12
|
Cefixime
|
Cefiryl
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
J.M. TOLMANN LABORATORIES INC
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
20 February 2029
|
| View |
|
DRP-5683-13
|
Cefixime
|
CEPRIME
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
J.M. TOLMANN LABORATORIES INC
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
20 February 2029
|
| View |
|
DRP-5683-22
|
Cefixime
|
Tropsiv
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
20 February 2029
|
| View |
|
DRP-5683-24
|
CEFIXIME
|
LUXIME
|
20mg/mL
|
Granules For Suspension (Oral Drops)
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Renewal
|
19 March 2024
|
20 February 2029
|
| View |
|
DRP-5685-11
|
Amlodipine (as Besilate)/ Losartan Potassium
|
Unbranded
|
5 mg/50 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker/Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
19 June 2024
|
28 October 2029
|
| View |
|
DRP-5715-03
|
Irbesartan
|
None
|
300 mg
|
Film-Coated Tablet
|
Angiotensin-2-receptor blocker (ARB)
|
Sanofi Winthrop Industrie-Carbon Blanc
|
France
|
CLIDP Conversion
|
01 March 2024
|
03 May 2027
|
| View |
|
DRP-5716-01
|
Irbesartan
|
None
|
150 mg
|
Film-coated Tablet
|
Angiotensin-2-receptor-blocker (ARB)
|
Sanofi Winthrop Industrie
|
France
|
CLIDP Conversion
|
14 February 2024
|
03 May 2027
|
| View |
|
DRP-5840-02
|
Pantoprazole (as sodium)
|
Pantobloc
|
40 mg
|
Lyophilized Powder for Injection (IV)
|
40 mg Lyophilized Powder for Injection (IV)
|
Shreechem Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 February 2024
|
26 May 2029
|